ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 154 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 2.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $55,000 | -30.4% | 30,000 | 0.0% | 0.01% | -31.6% |
Q2 2021 | $79,000 | -37.3% | 30,000 | -14.3% | 0.02% | -42.4% |
Q1 2021 | $126,000 | -43.5% | 35,000 | -60.5% | 0.03% | -52.9% |
Q4 2020 | $223,000 | -69.4% | 88,525 | -69.4% | 0.07% | -73.6% |
Q3 2020 | $728,000 | -4.1% | 289,025 | +24.6% | 0.26% | -7.0% |
Q2 2020 | $759,000 | +34.3% | 232,025 | +0.7% | 0.28% | +9.6% |
Q1 2020 | $565,000 | -75.4% | 230,525 | -52.6% | 0.26% | -39.4% |
Q4 2019 | $2,294,000 | +122.5% | 486,050 | +101.8% | 0.43% | -7.3% |
Q3 2019 | $1,031,000 | -18.5% | 240,800 | +11.0% | 0.46% | -19.9% |
Q2 2019 | $1,265,000 | +64.3% | 216,950 | +8.5% | 0.58% | +55.8% |
Q1 2019 | $770,000 | +118.1% | 199,950 | +5.8% | 0.37% | +71.0% |
Q4 2018 | $353,000 | – | 188,950 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |